Dr. Carlo Dufour for the latest and modern management of #FanconiAnemia. #ASH22 1/n
When to think about Fanconi anemia? Remember that genetic testing may be difficult to interpret and can be inconclusive - so correlation with clinical/functional studies is required. #ASH22 2/n
Extra hematologic assessment is required -- look how many places to check outside of the CBC in these patients. Think about Moya moya in your Fanconi anemia patients and take off your patient's mask and check their oral cavity for squam/mucosal cancers. #ASH22 3/n
Hematologic assessment -- why? to intercept these patients to go to transplant -- not just with CBC checks but also looking for chromosomal abnormalities. 1q is NOT the same as these others! Save this #phodocs in your files! #ASH22 4/n
Why does this matter? the outcomes (5 yr OS) is 42% if it goes on to MDS/AML and you're trying to transplant then -- as opposed to matched family donors prior to MDS/AML which have 88% 5-yr OS! #ASH22 5/n
There are some but's -- transplant can increase risk of other malignancies, and some can survive a long time without transplant. Here is the protocol they use at Gaslini Children's Hospital! Saving this for SURE! #ASH22 6/n
#Eltrombopag results that I had not seen from before in these Fanconi anemia patients. And of course, non conditioning required Fanconi anemia gene therapy results. "Attractive and catchy experimental treatment" per Dr. Dufour #ASH22 7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Two oral abstracts on the #STELLAR study (Sickle Cell Transplant Evaluation of Long-term and Late Effects Registry) presented by Dr. Sobenna George (hi!) and Dr. Lillian Meacham #ASH22 1/n
What's the problem? You can get DOR = diminished ovarian reserve or POI = primary ovarian insufficiency (early menopause). This is SUCH a good explanation!! #ASH22 2/n
Small numbers but such great data, 30 females and 18 males, about 4-6 years post therapy (myeloablative transplants (mostly matched sib) and one each with gene tx) #ASH22 3/n
They looked at 5022 patients with Rx of DMTs. Those on DMTs were surprisingly mostly in the 18-45 group (the box is wrong on the screenshot) and mostly male and had more VOCs. #ASH22 3/n
Management of pregnant women with #SCD in high income countries with Dr. Eugene Oteng-Ntim (with the cutest intro from Dr. Eugenia Asare). Writing down the #pearls here so I can share with my patients for their future and so I can advocate for them. #ASH22 1/n
As we know, more low/not detectable AMH levels in women with #SCD. Know that preimplantation diagnosis and successful transfer is possible with data to support that. And many want #NIPT secondary to fear of amnio or CVS, which can be done. (w/ @nonacus) #ASH22 2/n
What risks are we talking about in sickle cell disease and pregnancy? 1/4 of the patients in their cohort required transfusion during pregnancy and RR of preeclampsia is 2.43 and 3x risk of SGA, 4x risk of stillbirth. #ASH22 3/n
Dr. Mark Fleming talking about pathology vs molecular testing in MDS. He first reminds us the difference of childhood MDS from adult MDS -- and these WHO guidelines, childhood MDS is only classified into these two subtypes. #ASH22 1/n
The issue is that the "dysplasia" definition has been defined by the cytogenetic abnormalities and genotypes of adult MDS so the criteria for blast %age, extent of dysplasia -- but does this apply?? #ASH22 2/n
MDS in pediatric patients is more normo or hypocellular than hypercellular. There is not ringed sideroblasts in persons <30 and he also reminds us that there are a number of baseline dysplasias in germline BMF pts that are mistaken for MDS! #ASH22 3/n
#ASH22 Bone marrow failure syndromes: diagnostic principles in 2022. Starting with Sara Lewis, a genetic counselor in hematology. Follow this tweet for more. 1/n
Sara reminds us that she feels patients think more about their family history as they see her draw the pedigree. Time for me to start doing this! #phodocs#ASH22#pearl 2/n
Here are the options for diagnostic workup - genetic tests can be done from somatic genes or germline! #ASH22 3/n
@bhwords Dr. Beverley Hunt presenting on #COVID19 and #thrombosis. She wants to chronologically review the battles we have fought! #ASH22 1/n
@bhwords This story (clinical presentation) -- a reminder of the patients from the front lines in the beginning and what some docs went through! #COVID19#ASH22 2/n
@bhwords#COVID19 is the 'perfect suit for VTE' ... inflammation, sticky blood, vessel wall changes. The amazingly high levels of fibrinogen (14g/L! (normal is 2-4g/L)) D-dimers reported on a log scale because of the significant increase. #ASH22 3/n